Oxford, England – October 06, 2026 -- Perspectum, an Oxford-based precision health company, has appointed Warren Cresswell as Chief Executive Officer, bringing more than 25 years of diagnostics and medical device leadership to the firm's push into liver and cardiometabolic disease imaging. The placement was executed by Slone Partners, a nationwide executive search firm serving life sciences and healthcare organizations.
Cresswell previously led Nestlé-owned Prometheus Laboratories through a growth phase
Cresswell served as President and CEO of Prometheus Laboratories, a Nestlé Health Science company, where he directed the diagnostics business through a period of significant expansion. He has built commercial and CLIA-certified laboratory infrastructure supporting FDA-cleared diagnostics in the United States and most recently served as CEO of a precision oncology company.
Perspectum operates across the UK, EU, Asia, and USA
Perspectum develops non-invasive imaging solutions designed to accelerate drug development and improve patient outcomes in liver and cardiometabolic disease. The company combines biomedical science, clinical expertise, and quantitative imaging analytics to help clinicians detect disease earlier and make more informed care decisions.
Slone Partners' Sona Stroud led the search for Perspectum's board
Senior Partner Sona Stroud, who led the search, said Cresswell's combination of scientific and technology expertise with commercial and operational leadership was intended to translate innovation into clinical and business impact. Slone Partners CEO and Managing Partner Leslie Loveless said Cresswell's experience scaling organizations would support Perspectum's expansion of its technologies in drug development and patient care.
Perspectum Chairperson Dr. Michael Rosenblatt backs the board's selection
Dr. Michael Rosenblatt, Chairperson of Perspectum, said Cresswell's leadership talent and experience matched the company's current growth stage. Cresswell holds a BA in Chemistry from California State University and an MBA from the University of Pittsburgh.